2-[2-[[(2R)-1-hydroxy-3-methylbutan-2-yl]amino]-9-propan-2-ylpurin-6-yl]guanidine
C14H24N8O — CID 71654390
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-[[(2R)-1-hydroxy-3-methylbutan-2-yl]amino]-9-propan-2-ylpurin-6-yl]guanidine
2-[2-[[(2R)-1-hydroxy-3-methylbutan-2-yl]amino]-9-propan-2-ylpurin-6-yl]guanidine (PubChem CID 71654390) has the molecular formula C14H24N8O and a molecular weight of 320.40 g/mol. Its IUPAC name is 2-[2-[[(2R)-1-hydroxy-3-methylbutan-2-yl]amino]-9-propan-2-ylpurin-6-yl]guanidine.
Molecular Properties
| Compound Name | 2-[2-[[(2R)-1-hydroxy-3-methylbutan-2-yl]amino]-9-propan-2-ylpurin-6-yl]guanidine |
|---|---|
| PubChem CID | 71654390 |
| Molecular Formula | C14H24N8O |
| Molecular Weight | 320.40 g/mol |
| Exact Mass | 320.21 |
| IUPAC Name | 2-[2-[[(2R)-1-hydroxy-3-methylbutan-2-yl]amino]-9-propan-2-ylpurin-6-yl]guanidine |
| SMILES | CC(C)[C@H](CO)Nc1nc(N=C(N)N)c2ncn(C(C)C)c2n1 |
| InChI | InChI=1S/C14H24N8O/c1-7(2)9(5-23)18-14-20-11(19-13(15)16)10-12(21-14)22(6-17-10)8(3)4/h6-9,23H,5H2,1-4H3,(H5,15,16,18,19,20,21)/t9-/m0/s1 |
| InChIKey | ZSUORGHLMRHFOA-VIFPVBQESA-N |
| XLogP | 0.74 |
| TPSA | 140.26 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 320.40 |
| LogP ≤ 5 | 0.74 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 71654390 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.